1. Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
   Xinhang Xia et al, 2022, Analytical Cellular Pathology CrossRef